{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:51:43Z","timestamp":1792612303590,"version":"4.5.0"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","ejradiology.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejrad.2024.111908","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T11:52:47Z","timestamp":1735645967000},"page":"111908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Rare delayed hypersensitivity reactions to contrast media: Severe cutaneous adverse reactions"],"prefix":"10.1016","volume":"183","author":[{"given":"Aart J.","family":"van der Molen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick A.J.M.","family":"van de Ven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona A.","family":"Dekkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 J.","family":"Laguna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2024.111908_b0005","unstructured":"European Medicines Agency, Guideline on good pharmacovigilance practices (GVP). Annex I -Definitions (rev 5), Available at: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-good-pharmacovigilance-practices-annex-i-definitions-rev-5_en.pdf , 2024. (Accessed: 30 August 2024)."},{"key":"10.1016\/j.ejrad.2024.111908_b0010","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.iac.2021.12.001","article-title":"Hypersensitivity to radiocontrast dye","volume":"42","author":"Brockow","year":"2022","journal-title":"Immunol. Allergy. Clin. North. Am."},{"key":"10.1016\/j.ejrad.2024.111908_b0015","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1111\/all.15889","article-title":"Nomenclature ofallergicdiseases and hypersensitivity reactions, adapted to modern needs: An EAACI position paper","volume":"78","author":"Jutel","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.ejrad.2024.111908_b0020","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/ced.13991","article-title":"Contrast media and cutaneous reactions, part 2: delayed hypersensitivity reactions to iodinated contrast media","volume":"44","author":"Tasker","year":"2019","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.ejrad.2024.111908_b0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/all.13562","article-title":"EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity","volume":"74","author":"Brockow","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.ejrad.2024.111908_b0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.therap.2023.09.011","article-title":"Cutaneous adverse drug reactions","volume":"79","author":"Bettuzzi","year":"2024","journal-title":"Therapie."},{"key":"10.1016\/j.ejrad.2024.111908_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1259611","article-title":"Severe cutaneous adverse reactions to drugs: A real-world pharmacovigilance study using the FDA Adverse Event Reporting System database","volume":"14","author":"Li","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejrad.2024.111908_b0040","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.mcna.2021.04.001","article-title":"Recognition and management of severe cutaneous adverse drug reactions (including drug reaction with eosinophilia and systemic symptoms, Stevens-Johnson syndrome, and toxic epidermal necrolysis)","volume":"105","author":"Owen","year":"2021","journal-title":"Med. Clin. North. Am."},{"key":"10.1016\/j.ejrad.2024.111908_b0045","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000529218","article-title":"B, Meier-Schiesser, et al., Acute generalized exanthematous pustulosis: clinical characteristics, pathogenesis, and management","volume":"239","author":"Stadler","year":"2023","journal-title":"Dermatology"},{"key":"10.1016\/j.ejrad.2024.111908_b0050","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s40257-023-00779-3","article-title":"Acute generalized exanthematous pustulosis: clinical features, differential diagnosis, and management","volume":"24","author":"Parisi","year":"2023","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.ejrad.2024.111908_b0055","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15087","article-title":"Acute localized exanthematous pustulosis: Clinical features, pathophysiology, and therapy","volume":"34","author":"Safa","year":"2021","journal-title":"Dermatol. Ther"},{"key":"10.1016\/j.ejrad.2024.111908_b0060","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jaad.2015.07.017","article-title":"Acute generalized exanthematous pustulosis (AGEP): a review and update","volume":"73","author":"Szatkowski","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejrad.2024.111908_b0065","doi-asserted-by":"crossref","unstructured":"R. Cadot, P. Gery, V. Lenief, J.F. Nicolas, M. Vocanson, M. Tauber, Exploring recent advances in drugs severe cutaneous adverse reactions immunopathology, Allergy. 80 (2025) Online ahead of print, DOI: 10.1111\/all.16316.","DOI":"10.1111\/all.16316"},{"key":"10.1016\/j.ejrad.2024.111908_b0070","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1034\/j.1600-0560.2001.028003113.x","article-title":"Acute generalized exanthematous pustulosis (AGEP) \u2013 A clinical reaction pattern","volume":"28","author":"Sidoroff","year":"2001","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.ejrad.2024.111908_b0075","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1016\/j.jaip.2021.02.060","article-title":"FISARD group, DRESS and AGEP reactions to iodinated contrast media: a French case series","volume":"9","author":"Soria","year":"2021","journal-title":"J. Allergy. Clin. Immunol. Pract."},{"key":"10.1016\/j.ejrad.2024.111908_b0080","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1111\/jdv.16139","article-title":"Cutaneous tests and interest of iobitridol in non-immediate hypersensitivity to contrast media: a case series of 43 patients","volume":"34","author":"Gaudin","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ejrad.2024.111908_b0085","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1346-8138.2003.tb00466.x","article-title":"A case of acute generalized exanthematous pustulosis (AGEP) possibly induced by iohexol","volume":"30","author":"Atasoy","year":"2003","journal-title":"J. Dermatol."},{"key":"10.1016\/j.ejrad.2024.111908_b0090","first-page":"151","article-title":"A rare dermatologic reaction in an adult patient following coronary angiography: Acute generalized exanthematous pustulosis","volume":"18","author":"K\u0131l\u0131\u00e7","year":"2023","journal-title":"J. Tehran. Heart. Cent."},{"key":"10.1016\/j.ejrad.2024.111908_b0095","doi-asserted-by":"crossref","first-page":"E1097","DOI":"10.1503\/cmaj.200364","article-title":"Acute generalized exanthematous pustulosis caused by an intravenous radiocontrast medium","volume":"192","author":"Tan","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.ejrad.2024.111908_b0100","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archdermatol.2009.100","article-title":"Ioversol-induced acute generalized exanthematous pustulosis: a case report","volume":"145","author":"Hammerbeck","year":"2009","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ejrad.2024.111908_b0105","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.anai.2010.10.005","article-title":"Acute generalized exanthematous pustulosis caused by radiocontrast media","volume":"105","author":"Kim","year":"2010","journal-title":"Ann. Allergy. Asthma. Immunol."},{"key":"10.1016\/j.ejrad.2024.111908_b0110","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.anai.2010.06.018","article-title":"Acute generalized exanthematous pustulosis: the first pediatric case caused by a contrast agent","volume":"105","author":"Poliak","year":"2010","journal-title":"Ann. Allergy. Asthma. Immunol."},{"key":"10.1016\/j.ejrad.2024.111908_b0115","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bjd.12125","article-title":"A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions","volume":"168","author":"Barbaud","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejrad.2024.111908_b0120","doi-asserted-by":"crossref","unstructured":"A.Soria, C.Bernier, B.Milpied, H.Assier, F.Castelain, E.Amsler, et al, Administration of an alternative iodinated contrast media in confirmed severe delayed hypersensitivity reactions, J. Allergy. Clin. Immunol. Pract. 12 (2024) 1362-1367.e1, DOI: 10.1016\/j.jaip.2024.03.017.","DOI":"10.1016\/j.jaip.2024.03.017"},{"key":"10.1016\/j.ejrad.2024.111908_b0125","first-page":"66","article-title":"First case report of acute generalized exanthematous pustulosis due to intravenous iopromide","volume":"24","author":"Bavbek","year":"2014","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.ejrad.2024.111908_b0130","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jdcr.2020.08.006","article-title":"Acute generalized exanthematous pustulosis caused by iopamidol with recurrence on rechallenge with iopromide","volume":"6","author":"Mizuta","year":"2020","journal-title":"JAAD. Case. Rep."},{"key":"10.1016\/j.ejrad.2024.111908_b0135","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0151-9638(04)93772-6","article-title":"Acute generalized exanthematous pustulosis induced by iopamidol [in French]","volume":"131","author":"Belgod\u00e8re","year":"2004","journal-title":"Ann. Dermatol. Venereol."},{"key":"10.1016\/j.ejrad.2024.111908_b0140","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5021\/ad.2010.22.2.163","article-title":"Clinicopathologic manifestations of 36 Korean patients with acute generalized exanthematous pustulosis: a case series and review of the literature","volume":"22","author":"Choi","year":"2010","journal-title":"Ann. Dermatol."},{"key":"10.1016\/j.ejrad.2024.111908_b0145","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/ced.13920","article-title":"Accidental re-exposure causing repeated severe acute generalized exanthematous pustulosis","volume":"44","author":"O\u2019Driscoll","year":"2019","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.ejrad.2024.111908_b0150","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jaip.2014.07.015","article-title":"Iodinated contrast media-induced acute generalized exanthematous pustulosis confirmed by delayed skin tests","volume":"2","author":"Grandvuillemin","year":"2014","journal-title":"J. Allergy. Clin. Immunol. Pract."},{"key":"10.1016\/j.ejrad.2024.111908_b0155","doi-asserted-by":"crossref","unstructured":"P.Machet, D.Marc\u00e9, Y.Ziyani, M.Dumont, H.Cornillier, A.P.Jonville-Bera, et al, Acute generalized exanthematous pustulosis induced by iomeprol with cross-reactivity to other iodinated contrast agents and mild reactions after rechallenge with iopromide and oral corticosteroid premedication, Contact. Dermatitis. 81 (2019) 74-76, DOI: 10.1111\/cod.13242.","DOI":"10.1111\/cod.13242"},{"key":"10.1016\/j.ejrad.2024.111908_b0160","first-page":"601","article-title":"Case of the month. Acute generalized exanthematous pustulosis due to an iodinated contrast radiodiagnostic agent [in French]","volume":"64","author":"Paquet","year":"2009","journal-title":"Rev. Med. Liege."},{"key":"10.1016\/j.ejrad.2024.111908_b0165","doi-asserted-by":"crossref","first-page":"W198","DOI":"10.2214\/AJR.05.0317","article-title":"Acute generalized exanthematous pustulosis as a delayed dermatotoxic reaction to IV administered nonionic contrast media","volume":"187","author":"Peterson","year":"2006","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2024.111908_b0170","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/15569527.2014.961071","article-title":"Acute generalized exanthematous pustulosis induced by iodixanol (Visipaque): a serious reaction to a commonly used drug","volume":"34","author":"Ozturk","year":"2015","journal-title":"Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.ejrad.2024.111908_b0175","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/cod.12724","article-title":"Acute generalized exanthematous pustulosis caused by an iodinated contrast radiocontrast medium for computed tomography arthrography of the knee","volume":"76","author":"Velter","year":"2017","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.ejrad.2024.111908_b0180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/cod.13790","article-title":"Acute localized exanthematous pustulosis (ALEP) induced by iomeprol (Iomeron 350): A diagnostic challenge","volume":"85","author":"Navarro Trivi\u00f1o","year":"2021","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.ejrad.2024.111908_b0185","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/cod.14465","article-title":"Acute localised exanthematous pustulosis (ALEP) -induced by ioversol, Contact","volume":"90","author":"Xie","year":"2024","journal-title":"Dermatitis"},{"key":"10.1016\/j.ejrad.2024.111908_b0190","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/cod.12878","article-title":"First case report of acute generalized exanthematous pustulosis (AGEP) caused by gadolinium confirmed by patch testing","volume":"78","author":"Bordel G\u00f3mez","year":"2018","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.ejrad.2024.111908_b0195","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/cod.14562","article-title":"A rare case of acute generalized exanthematous pustulosis induced by gadobutrol, Contact","volume":"91","author":"Fetzer","year":"2024","journal-title":"Dermatitis"},{"key":"10.1016\/j.ejrad.2024.111908_b0200","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaad.2019.09.036","article-title":"Drug reaction with eosinophilia and systemic symptoms may occur within 2 weeks of drug exposure: A retrospective study","volume":"82","author":"Soria","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejrad.2024.111908_b0205","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jaip.2022.02.004","article-title":"Drug-Induced Hypersensitivity Syndrome (DIHS)\/Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): clinical features and pathogenesis","volume":"10","author":"Hama","year":"2022","journal-title":"J. Allergy. Clin. Immunol. Pract."},{"key":"10.1016\/j.ejrad.2024.111908_b0210","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jaad.2023.02.072","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis","volume":"90","author":"Wei","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejrad.2024.111908_b0215","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaad.2023.02.073","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management","volume":"90","author":"Wei","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejrad.2024.111908_b0220","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1111\/all.16122","article-title":"Medical algorithm: Diagnosis and treatment of drug reaction with eosinophilia and systemic symptoms in adult patients","volume":"79","author":"Br\u00fcggen","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.ejrad.2024.111908_b0225","doi-asserted-by":"crossref","unstructured":"J.G. Peter, R.Lehloenya, S.Dlamini, K.Risma, K.D.White, K.C.Konvinse, et al., Severe delayed cutaneous and systemic reactions to drugs: a global perspective on the science and art of current practice, J. Allergy. Clin. Immunol. Pract. 5 (2017) 547-563, DOI: 10.1016\/j.jaip.2017.01.025.","DOI":"10.1016\/j.jaip.2017.01.025"},{"key":"10.1016\/j.ejrad.2024.111908_b0230","doi-asserted-by":"crossref","unstructured":"S.H. Kardaun, P.Sekula, L.Valeyrie-Allanore, Y.Liss, C.Y.Chu, D.Creamer, et al., Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study, Br. J. Dermatol. 169 (2013) 1071-1080, DOI: 10.1111\/bjd.12501.","DOI":"10.1111\/bjd.12501"},{"key":"10.1016\/j.ejrad.2024.111908_b0235","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1398-9995.2008.01689.x","article-title":"DRESS syndrome induced by sodium meglumine ioxitalamate","volume":"63","author":"Belhadjali","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.ejrad.2024.111908_b0240","first-page":"93","article-title":"DRESS syndrome due to iodinated contrast medium, N. Z","volume":"133","author":"Alamri","year":"2020","journal-title":"Med. J."},{"key":"10.1016\/j.ejrad.2024.111908_b0245","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaci.2004.09.012","article-title":"T cell-mediated reactions to iodinated contrast media: evaluation by skin and lymphocyte activation tests","volume":"115","author":"Kanny","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejrad.2024.111908_b0250","first-page":"56","article-title":"DRESS syndrome involving two unrelated substances: imipenem and iodinated contrast media","volume":"23","author":"Mac\u00edas","year":"2013","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.ejrad.2024.111908_b0255","doi-asserted-by":"crossref","unstructured":"G.Zambrano Ibarra, B.Noguerado Mellado, P.Tornero Molina, C.Cuevas Bravo, P.Rojas P\u00e9rez-Esquerra, DRESS syndrome due to iodinated contrast media. A case report. Allergy. Asthma. Clin. Immunol. 19 (2023) 16, DOI: 10.1186\/s13223-023-00774-7.","DOI":"10.1186\/s13223-023-00774-7"},{"key":"10.1016\/j.ejrad.2024.111908_b0260","doi-asserted-by":"crossref","first-page":"238","DOI":"10.18176\/jiaci.0742","article-title":"DRESS syndrome induced by a gadolinium-based contrast agent in a 13-year-old boy","volume":"32","author":"Mac\u00edas-Iglesias","year":"2022","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.ejrad.2024.111908_b0265","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40257-020-00505-3","article-title":"Fixed drug eruptions: An update, emphasizing the potentially lethal generalized bullous fixed drug eruption","volume":"21","author":"Patel","year":"2020","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.ejrad.2024.111908_b0270","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3390\/medicina57090925","article-title":"A review of fixed drug eruption with a special focus on generalized bullous fixed drug eruption","volume":"57","author":"Anderson","year":"2021","journal-title":"Medicina"},{"key":"10.1016\/j.ejrad.2024.111908_b0275","doi-asserted-by":"crossref","unstructured":"P.Shrestha, C.A.Stone Jr, E.J.Phillips, Fixed drug eruption and generalized bullous fixed drug eruption: Insights from an analysis of the FDA Adverse Event Reporting System, J. Allergy. Clin. Immunol. Pract. 13 (2025) Online ahead of print, DOI: 10.1016\/j.jaip.2024.09.024.","DOI":"10.1016\/j.jaip.2024.09.024"},{"key":"10.1016\/j.ejrad.2024.111908_b0280","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/bjd.12133","article-title":"Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"168","author":"Lipowicz","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejrad.2024.111908_b0285","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/08998280.2019.1644147","article-title":"Contrast-induced generalized bullous fixed drug eruption resembling Stevens-Johnson syndrome","volume":"32","author":"Gavin","year":"2019","journal-title":"Proc. Bayl. Univ. Med. Cent."},{"key":"10.1016\/j.ejrad.2024.111908_b0290","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.amjmed.2022.07.010","article-title":"Generalized bullous fixed drug eruption to iodinated contrast media in skin of color","volume":"135","author":"Tsang","year":"2022","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejrad.2024.111908_b0295","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/jid.2012.510","article-title":"RegiSCAR study group, Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"133","author":"Sekula","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejrad.2024.111908_b0300","article-title":"Causes and management of cutaneous adverse drug reactions: a comprehensive review","volume":"16","author":"Sutaria","year":"2024","journal-title":"Cureus."},{"key":"10.1016\/j.ejrad.2024.111908_b0305","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejrad.2024.111908_b0310","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejrad.2024.111908_b0315","doi-asserted-by":"crossref","unstructured":"B.Sassolas, C.Haddad, M.Mockenhaupt, A.Dunant, Y.Liss, K.Bork, et al., ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis, Clin. Pharmacol. Ther. 88 (2010) 60-68, DOI: 10.1038\/clpt.2009.252.","DOI":"10.1038\/clpt.2009.252"},{"key":"10.1016\/j.ejrad.2024.111908_b0320","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002521","article-title":"T cell mediated hypersensitivity to previously tolerated iodinated contrast media precipitated by introduction of atezolizumab","volume":"9","author":"Hammond","year":"2021","journal-title":"J. Immunother. Cancer."},{"key":"10.1016\/j.ejrad.2024.111908_b0325","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/pgmj.64.751.392","article-title":"Fatal Stevens-Johnson syndrome following urography with iopamidol in systemic lupus erythematosus","volume":"64","author":"Savill","year":"1988","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.ejrad.2024.111908_b0330","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jaad.2003.07.017","article-title":"Intravenous immunoglobulin prophylaxis for recurrent Stevens-Johnson syndrome","volume":"50","author":"Hebert","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"issue":"684","key":"10.1016\/j.ejrad.2024.111908_b0335","first-page":"e5","article-title":"Probable parenteral and oral contrast-induced Stevens- Johnson syndrome\/toxic epidermal necrolysis","volume":"45","author":"Pop","year":"2021","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.ejrad.2024.111908_b0340","first-page":"1","article-title":"Non-ionic contrast allergy manifesting as Stevens Johnson Syndrome and Erythema Multiforme","volume":"1","author":"Gogna","year":"2015","journal-title":"J. Adv. Allergy. Immunol. Dis."},{"key":"10.1016\/j.ejrad.2024.111908_b0345","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2133.2003.05763.x","article-title":"Severe Stevens-Johnson syndrome induced by contrast medium iopentol (Imagopaque)","volume":"150","author":"Laffitte","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejrad.2024.111908_b0350","doi-asserted-by":"crossref","first-page":"561","DOI":"10.47102\/annals-acadmedsg.V44N12p561","article-title":"Severe cutaneous adverse reactions following intravenous contrast: a report of 2 cases","volume":"44","author":"Yang","year":"2015","journal-title":"Ann. Acad. Med. Singap."},{"key":"10.1016\/j.ejrad.2024.111908_b0355","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-4362.1988.tb02369.x","article-title":"Toxic epidermal necrolysis after excretory pyelography. Immunologic-mediated contrast medium reaction?","volume":"27","author":"Kaftori","year":"1988","journal-title":"Int .J. Dermatol."},{"key":"10.1016\/j.ejrad.2024.111908_b0360","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1346-8138.1995.tb03881.x","article-title":"An autopsy case of malignant lymphoma with Lyell's syndrome","volume":"22","author":"Sadi","year":"1995","journal-title":"J. Dermatol."},{"key":"10.1016\/j.ejrad.2024.111908_b0365","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2214\/ajr.176.1.1760262","article-title":"Toxic epidermal necrolysis after repeated injections of iohexol","volume":"176","author":"Rosado","year":"2001","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2024.111908_b0370","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0167-5273(01)00585-X","article-title":"Toxic epidermal necrolysis incriminating iopamidol in a child after cardiac catheterization","volume":"82","author":"Lee","year":"2002","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejrad.2024.111908_b0375","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5694\/mja14.00367","article-title":"Toxic epidermal necrolysis - an investigation to dye for?","volume":"202","author":"Ly","year":"2015","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.ejrad.2024.111908_b0380","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1097\/BCR.0b013e318257d88e","article-title":"Recurrent toxic epidermal necrolysis secondary to iopromide contrast","volume":"34","author":"Brown","year":"2013","journal-title":"J. Burn. Care. Res."},{"key":"10.1016\/j.ejrad.2024.111908_b0385","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.gie.2005.06.034","article-title":"A case of toxic epidermal necrolysis with involvement of the GI tract after systemic contrast agent application at cardiac catheterization","volume":"62","author":"Garza","year":"2005","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/j.ejrad.2024.111908_b0390","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2214\/ajr.171.5.9798850","article-title":"Toxic epidermal necrolysis related to oral administration of diluted diatrizoate meglumine and diatrizoate sodium, AJR","volume":"171","author":"Schmidt","year":"1998","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2024.111908_b0395","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.573573","article-title":"An updated review of the diagnostic methods in delayed drug hypersensitivity","volume":"11","author":"Copaescu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejrad.2024.111908_b0400","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaci.2018.10.030","article-title":"Controversies in drug allergy: Testing for delayed reactions","volume":"143","author":"Phillips","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejrad.2024.111908_b0405","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/cod.14063","article-title":"Skin tests in the work-up of cutaneous adverse drug reactions: A review and update, Contact","volume":"86","author":"Barbaud","year":"2022","journal-title":"Dermatitis"},{"key":"10.1016\/j.ejrad.2024.111908_b0410","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.jaip.2024.06.047","article-title":"Delayed skin testing for systemic medications: Helpful or not?","volume":"12","author":"Barbaud","year":"2024","journal-title":"J. Allergy. Clin. Immunol. Pract."},{"key":"10.1016\/j.ejrad.2024.111908_b0415","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaci.2018.09.022","article-title":"Controversies in drug allergy: In vitro testing","volume":"143","author":"Mayorga","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejrad.2024.111908_b0420","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1398-9995.2004.00547.x","article-title":"The lymphocyte transformation test in the diagnosis of drug hypersensitivity","volume":"59","author":"Pichler","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.ejrad.2024.111908_b0425","doi-asserted-by":"crossref","unstructured":"R.Caba\u00f1as, O.Calder\u00f3n, E.Ram\u00edrez, A.Fiandor, T.Caballero, R.Heredia, et al., Sensitivity and specificity of the lymphocyte transformation test in drug reaction with eosinophilia and systemic symptoms causality assessment, Clin. Exp. Allergy. 48 (2018) 325-333, DOI: 10.1111\/cea.13076.","DOI":"10.1111\/cea.13076"},{"key":"10.1016\/j.ejrad.2024.111908_b0430","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/cod.12432","article-title":"European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practice","volume":"73","author":"Johansen","year":"2015","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.ejrad.2024.111908_b0435","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/DER.0000000000000839","article-title":"Patch testing in drug eruptions: practical aspects and literature review of eruptions and culprit drugs","volume":"33","author":"De Groot","year":"2022","journal-title":"Dermatitis"},{"key":"10.1016\/j.ejrad.2024.111908_b0440","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.anai.2023.01.006","article-title":"Drug patch testing in Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review","volume":"130","author":"Novack","year":"2023","journal-title":"Ann. Allergy. Asthma. Immunol."},{"key":"10.1016\/j.ejrad.2024.111908_b0445","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jaip.2022.09.011","article-title":"Utility and safety of skin tests in drug reaction with eosinophilia and systemic symptoms (DRESS): A systematic review","volume":"11","author":"Teo","year":"2023","journal-title":"J. Allergy. Clin. Immunol. Pract."},{"key":"10.1016\/j.ejrad.2024.111908_b0450","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/bjd.17835","article-title":"Are drug intradermal tests dangerous to explore cross-reactivity and co-sensitization in DRESS?","volume":"181","author":"Soria","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejrad.2024.111908_b0455","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fmed.2020.00156","article-title":"Intradermal tests with drugs: an approach to standardization","volume":"7","author":"Barbaud","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.ejrad.2024.111908_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2024.100946","article-title":"Drug provocation tests (DPTs) of contrast media: Useful or not useful? A narrative review","volume":"17","author":"Dettwiler","year":"2024","journal-title":"World. Allergy. Organ. J."},{"key":"10.1016\/j.ejrad.2024.111908_b0465","doi-asserted-by":"crossref","unstructured":"M.J.Torres, A.Trautmann, I.B\u00f6hm, K.Scherer, A.Barbaud, S.Bavbek, et al., Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity, Allergy. 76 (2021) 1325-1339, DOI: 10.1111\/all.14656.","DOI":"10.1111\/all.14656"},{"key":"10.1016\/j.ejrad.2024.111908_b0470","doi-asserted-by":"crossref","unstructured":"A.Barbaud, L.H.Garvey, M.J.Torres, J.J.Laguna, A.Arcolaci, P.Bonadonna, et al., EAACI\/ENDA position paper on drug provocation testing, Allergy. 79 (2024) 565-579, DOI: 10.1111\/all.15996.","DOI":"10.1111\/all.15996"},{"key":"10.1016\/j.ejrad.2024.111908_b0475","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1016\/j.jaip.2022.07.008","article-title":"Skin testing and drug provocation tests in epidermal necrolysis: a French experience","volume":"10","author":"Roux","year":"2022","journal-title":"J. Allergy. Clin. Immunol. Pract."},{"key":"10.1016\/j.ejrad.2024.111908_b0480","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/all.12589","article-title":"Skin tests in patients with hypersensitivity reaction to iodinated contrast media: A meta-analysis","volume":"70","author":"Yoon","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.ejrad.2024.111908_b0485","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jaip.2017.10.040","article-title":"Skin testing for suspected iodinated contrast media hypersensitivity","volume":"6","author":"Schrijvers","year":"2018","journal-title":"J. Allergy. Clin. Immunol. Pract."},{"key":"10.1016\/j.ejrad.2024.111908_b0490","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/RLI.0000000000000765","article-title":"Finding the optimal alternative for immediate hypersensitivity to low-osmolar iodine-based contrast","volume":"56","author":"Sohn","year":"2021","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.ejrad.2024.111908_b0495","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/RCT.0000000000001462","article-title":"Contrast agent selection to prevent recurrent severe hypersensitivity reaction to iodinated contrast media based on nationwide database","volume":"47","author":"Ahn","year":"2023","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.ejrad.2024.111908_b0500","doi-asserted-by":"crossref","unstructured":"I.M.Ghiordanescu, N.Molinari, I.Ciocanea-Teodorescu, R.Schrijvers, C.Motei, A.M.Forsea, et al., Skin test reactivity patterns in patients allergic to iodinated contrast media: a refined view, J. Allergy. Clin. Immunol. Pract. 12 (2024) 705-713.E6, DOI: 10.1016\/j.jaip.2023.10.040.","DOI":"10.1016\/j.jaip.2023.10.040"},{"key":"10.1016\/j.ejrad.2024.111908_b0505","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1007\/s00330-024-10872-8","article-title":"Cross-reactivity in prevention of recurrent hypersensitivity reactions after iodine-based contrast media and gadolinium-based contrast agents: Practical contrast agent classification and guide for clinical practice","volume":"34","author":"Vega","year":"2024","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2024.111908_b0510","first-page":"933","article-title":"Skin test results and cross-reactivity patterns in IgE- and T-cell-mediated allergy to gadolinium-based contrast agents, Allergy. Asthma","volume":"13","author":"Grueber","year":"2021","journal-title":"Immunol. Res."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X24006247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X24006247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T16:01:01Z","timestamp":1745942461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X24006247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":102,"alternative-id":["S0720048X24006247"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2024.111908","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rare delayed hypersensitivity reactions to contrast media: Severe cutaneous adverse reactions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2024.111908","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111908"}}